Access to an Educational Video Preoperatively Has No Effect on Postoperative Opioid Use After Arthroscopic Partial Meniscectomy of the Knee: A Prospective Cohort Study.

Autor: Lubitz MG; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A., Latario L; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A., Ogbeide-Latario O; University of Massachusetts Chan Medical Science Training Program, Worcester, Massachusetts, U.S.A., Hughes K; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A., Clegg S; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A., Molla V; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A., Brown M; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A., Busconi B; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A., DeAngelis N; Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Chan, School of Medicine, Worcester, Massachusetts, U.S.A.

Publikováno v: Arthroscopy, sports medicine, and rehabilitation [Arthrosc Sports Med Rehabil] 2024 Feb 27; Vol. 6 (2), pp. 100885. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).

Sustained Minimal Residual Disease Negativity With Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONE

Autor: San-Miguel, JF, Avet-Loiseau, H, Paiva, B, Kumar, SK, Dimopoulos, MAA, Facon, T, Mateos, M-V, Touzeau, C, Jakubowiak, AJ, Usmani, SZ, Cook, G, Cavo, M, Quach, H, Ukropec, J, Ramaswami, P, Pei, H, Qi, M, Sun, S, Wang, J, Krevvata, M, DeAngelis, N, Heuck, C, Van Rampelbergh, R, Kudva, A, Kobos, R, Bahlis, NJ

In patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM), daratumumab reduced the risk of disease progression or death by 44% in MAIA (daratumumab/lenalidomide/dexamethasone; D-Rd) and 58% in ALCYONE (daratumumab/bortezomib/melp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::04aa18714d279dc6478c80ac17290cab

Liver trauma: WSES 2020 guidelines

Autor: Coccolini F., Coimbra R., Ordonez C., Kluger Y., Vega F., Moore E. E., Biffl W., Peitzman A., Horer T., Abu-Zidan F. M., Sartelli M., Fraga G. P., Cicuttin E., Ansaloni L., Parra M. W., Millan M., Deangelis N., Inaba K., Velmahos G., Maier R., Khokha V., Sakakushev B., Augustin G., Di Saverio S., Pikoulis E., Chirica M., Reva V., Leppaniemi A., Manchev V., Chiarugi M., Damaskos D., Weber D., Parry N., Demetrashvili Z., Civil I., Napolitano L., Corbella D., Catena F., Bahouth H., Tolonen M., Fugazzola P., Serna J. J., Rodriguez F., Garcia A. F., Gonzalez A., Pino L. F., Guzman-Rodriguez M., Pereira B. M., Kirkpatrick A., Mefire A. C., Tarasconi A., Chiara O., Gomes C. A., Galante J., Bala M., Perfetti P., MacHado F., Romeo O., Salvetti F., Ghiadoni L., Forfori F., Malacarne P., Pini S., Pucciarelli M., Ceresoli M., Arvieux C., Khokha D., Spain D. A., Isik A.

Publikováno v: World Journal of Emergency Surgery, Vol 15, Iss 1, Pp 1-15 (2020)
World Journal of Emergency Surgery : WJES

Liver injuries represent one of the most frequent life-threatening injuries in trauma patients. In determining the optimal management strategy, the anatomic injury, the hemodynamic status, and the associated injuries should be taken into consideratio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b44050a23173f2def947201806e9a6
http://hdl.handle.net/10281/393789

Duodeno-pancreatic and extrahepatic biliary tree trauma: WSES-AAST guidelines

Autor: Coccolini, F. Kobayashi, L. Kluger, Y. Moore, E.E. Ansaloni, L. Biffl, W. Leppaniemi, A. Augustin, G. Reva, V. Wani, I. Kirkpatrick, A. Abu-Zidan, F. Cicuttin, E. Fraga, G.P. Ordonez, C. Pikoulis, E. Sibilla, M.G. Maier, R. Matsumura, Y. Masiakos, P.T. Khokha, V. Mefire, A.C. Ivatury, R. Favi, F. Manchev, V. Sartelli, M. Machado, F. Matsumoto, J. Chiarugi, M. Arvieux, C. Catena, F. Coimbra, R. Ben-Ishay, O. Tolonen, M. Bertelli, R. Horer, T. Ferrada, P. Di Carlo, I. Pereira, B.M. Parini, D. Montori, G. De Simone, B. Chiara, O. Hecker, A. Deangelis, N. Gomes, C.A. Galante, J. Bala, M. Mylonas, K.S. Pikoulis, A. Perfetti, P. Chirica, M. Bado, J. Inaba, K. Parry, N. Romeo, O. Stommel, M. Rajashekar, M. Tan, E. Salvetti, F. Sakakushev, B.

Duodeno-pancreatic and extrahepatic biliary tree injuries are rare in both adult and pediatric trauma patients, and due to their anatomical location, associated injuries are very common. Mortality is primarily related to associated injuries, but morb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::e6ea9b4026b1dcc2a67a9bcb024b9afc
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105336

Discovery and pharmacological characterization of cetrelimab (JNJ-63723283), an anti-programmed cell death protein-1 (PD-1) antibody, in human cancer models.

Autor: DeAngelis N; Oncology Therapeutic Area, Janssen Research & Development, Spring House, PA, USA., Ferrante C; Oncology Therapeutic Area, Janssen Research & Development, Spring House, PA, USA., Powers G; Biologics Research, Janssen Research & Development, Spring House, PA, USA., Sendecki J; Translational Medicine and Early Development Statistics, Janssen Research & Development, Spring House, PA, USA., Mattson B; Oncology Therapeutic Area, Janssen Research & Development, Spring House, PA, USA., Pizutti D; Oncology Therapeutic Area, Janssen Research & Development, Spring House, PA, USA., Packman K; Oncology Therapeutic Area, Janssen Research & Development, Spring House, PA, USA., Wang W; Biologics Development Sciences, Janssen Research & Development, Spring House, PA, USA., Trouba K; Nonclinical Safety, Janssen Research & Development, Spring House, Pennsylvania, USA., Nanjunda R; Biologics Research, Janssen Research & Development, Spring House, PA, USA., Wheeler J; Biologics Research, Janssen Research & Development, Spring House, PA, USA., Brittingham R; Biologics Research, Janssen Research & Development, Spring House, PA, USA., Wu SJ; Biologics Research, Janssen Research & Development, Spring House, PA, USA., Luo J; Biologics Research, Janssen Research & Development, Spring House, PA, USA., Lorenzi MV; Oncology Therapeutic Area, Janssen Research & Development, Spring House, PA, USA., Verona RI; Oncology Therapeutic Area, Janssen Research & Development, Spring House, PA, USA. rverona@its.jnj.com.

Publikováno v: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Apr; Vol. 89 (4), pp. 515-527. Date of Electronic Publication: 2022 Mar 17.